In the News

Dartmouth, Company to Share $4.7M in Opioid Treatment Funds – NHPR via Associated Press

Read article – Dartmouth and a healthcare technology company called Q2i are sharing $4.7 million in federal grant money to work on improving the treatment of opioid addiction. The funding is from the National Institutes of Health for a program that provides resources to test new approaches aimed at improving treatment for chronic pain, curbing the rates of opioid use disorder and overdoses, and achieving long-term recovery from opioid addiction. (Picked up by WMUR, NBC 5, WCAX, and Charlotte Observer. Similar coverage in New Hampshire Union Leader.)

In Tiny Doses, an Addiction Medication Moonlights as Treatment for Chronic Pain – Kaiser Health News via NPR

Listen to story – Continued coverage of comments by Bruce Vrooman, associate professor of anesthesiology, about treating patients with complex chronic pain, and how for some patients, low-dose naltrexone appears to be more effective and well-tolerated than the big-name opioids that dominated pain management for decades. (Picked up by Yahoo! Lifestyle and Pain News Network.)

Lebanon Accelerator Wins $50k in SBA Competition – New Hampshire Business Review

Read article – TREAT, the Lebanon-based Center for the Translation of Rehabilitation Engineering Advances in Technology, has been awarded a $50,000 grant in the U.S. Small Business Administration’s Growth Accelerator Fund Competition. TREAT is a consortium that includes Dartmouth’s Geisel School of Medicine and Tuck School of Business and Celdara Medical, a biotech firm based in Lebanon, among several others.

California Health Officials Tell Everyone to Stop Vaping Right Now – Los Angeles Times

Read article – Quotes James Sargent, the Scott M. and Lisa G. Stuart Professor, in an article reporting about how California health officials issued a warning Tuesday urging people to stop vaping immediately, joining a growing chorus of health experts advising caution around e-cigarette use following recent reports of severe lung illnesses linked to the practice.

In Tiny Doses, an Addiction Medication Moonlights as a Treatment for Chronic Pain – NHPR via NPR

Listen to story – Continued coverage of comments by Bruce Vrooman, associate professor of anesthesiology, about treating patients with complex chronic pain, and how for some patients, low-dose naltrexone appears to be more effective and well-tolerated than the big-name opioids that dominated pain management for decades. “Those patients may report that this is indeed a game-changer,” Vrooman says. “It may truly help them with their activities, help them feel better.”

In Tiny Doses, an Addiction Medication Moonlights as a Treatment for Chronic Pain – NPR

Listen to story – Quotes Bruce Vrooman, associate professor of anesthesiology, about treating patients with complex chronic pain, and how for some patients, low-dose naltrexone appears to be more effective and well-tolerated than the big-name opioids that dominated pain management for decades. “Those patients may report that this is indeed a game-changer,” Vrooman says. “It may truly help them with their activities, help them feel better.” (Picked up by WAMU.)